Chromosomal instability in mammalian pre-implantation embryos: potential causes, detection methods, and clinical consequences

Brittany L. Daughtry, Shawn Chavez

    Research output: Contribution to journalArticle

    24 Citations (Scopus)

    Abstract

    Formation of a totipotent blastocyst capable of implantation is one of the first major milestones in early mammalian embryogenesis, but less than half of in vitro fertilized embryos from most mammals will progress to this stage of development. Whole chromosomal abnormalities, or aneuploidy, are key determinants of whether human embryos will arrest or reach the blastocyst stage. Depending on the type of chromosomal abnormality, however, certain embryos still form blastocysts and may be morphologically indistinguishable from chromosomally normal embryos. Despite the implementation of pre-implantation genetic screening and other advanced in vitro fertilization (IVF) techniques, the identification of aneuploid embryos remains complicated by high rates of mosaicism, atypical cell division, cellular fragmentation, sub-chromosomal instability, and micro-/multi-nucleation. Moreover, several of these processes occur in vivo following natural human conception, suggesting that they are not simply a consequence of culture conditions. Recent technological achievements in genetic, epigenetic, chromosomal, and non-invasive imaging have provided additional embryo assessment approaches, particularly at the single-cell level, and clinical trials investigating their efficacy are continuing to emerge. In this review, we summarize the potential mechanisms by which aneuploidy may arise, the various detection methods, and the technical advances (such as time-lapse imaging, “-omic” profiling, and next-generation sequencing) that have assisted in obtaining this data. We also discuss the possibility of aneuploidy resolution in embryos via various corrective mechanisms, including multi-polar divisions, fragment resorption, endoreduplication, and blastomere exclusion, and conclude by examining the potential implications of these findings for IVF success and human fecundity.

    Original languageEnglish (US)
    Pages (from-to)201-225
    Number of pages25
    JournalCell and Tissue Research
    Volume363
    Issue number1
    DOIs
    StatePublished - Jan 1 2016

    Fingerprint

    Chromosomal Instability
    Embryonic Structures
    Aneuploidy
    Blastocyst
    Fertilization in Vitro
    Chromosome Aberrations
    Endoreduplication
    Time-Lapse Imaging
    Blastomeres
    Mosaicism
    Genetic Testing
    Epigenomics
    Cell Division
    Embryonic Development
    Fertility
    Mammals
    Clinical Trials

    Keywords

    • Aneuploidy
    • Chromothripsis
    • Fragmentation
    • Micronuclei
    • Pre-implantation embryo

    ASJC Scopus subject areas

    • Pathology and Forensic Medicine
    • Cell Biology
    • Histology

    Cite this

    Chromosomal instability in mammalian pre-implantation embryos : potential causes, detection methods, and clinical consequences. / Daughtry, Brittany L.; Chavez, Shawn.

    In: Cell and Tissue Research, Vol. 363, No. 1, 01.01.2016, p. 201-225.

    Research output: Contribution to journalArticle

    @article{f5ffdc834aae446cafbb8d258ba356e4,
    title = "Chromosomal instability in mammalian pre-implantation embryos: potential causes, detection methods, and clinical consequences",
    abstract = "Formation of a totipotent blastocyst capable of implantation is one of the first major milestones in early mammalian embryogenesis, but less than half of in vitro fertilized embryos from most mammals will progress to this stage of development. Whole chromosomal abnormalities, or aneuploidy, are key determinants of whether human embryos will arrest or reach the blastocyst stage. Depending on the type of chromosomal abnormality, however, certain embryos still form blastocysts and may be morphologically indistinguishable from chromosomally normal embryos. Despite the implementation of pre-implantation genetic screening and other advanced in vitro fertilization (IVF) techniques, the identification of aneuploid embryos remains complicated by high rates of mosaicism, atypical cell division, cellular fragmentation, sub-chromosomal instability, and micro-/multi-nucleation. Moreover, several of these processes occur in vivo following natural human conception, suggesting that they are not simply a consequence of culture conditions. Recent technological achievements in genetic, epigenetic, chromosomal, and non-invasive imaging have provided additional embryo assessment approaches, particularly at the single-cell level, and clinical trials investigating their efficacy are continuing to emerge. In this review, we summarize the potential mechanisms by which aneuploidy may arise, the various detection methods, and the technical advances (such as time-lapse imaging, “-omic” profiling, and next-generation sequencing) that have assisted in obtaining this data. We also discuss the possibility of aneuploidy resolution in embryos via various corrective mechanisms, including multi-polar divisions, fragment resorption, endoreduplication, and blastomere exclusion, and conclude by examining the potential implications of these findings for IVF success and human fecundity.",
    keywords = "Aneuploidy, Chromothripsis, Fragmentation, Micronuclei, Pre-implantation embryo",
    author = "Daughtry, {Brittany L.} and Shawn Chavez",
    year = "2016",
    month = "1",
    day = "1",
    doi = "10.1007/s00441-015-2305-6",
    language = "English (US)",
    volume = "363",
    pages = "201--225",
    journal = "Cell and Tissue Research",
    issn = "0302-766X",
    publisher = "Springer Verlag",
    number = "1",

    }

    TY - JOUR

    T1 - Chromosomal instability in mammalian pre-implantation embryos

    T2 - potential causes, detection methods, and clinical consequences

    AU - Daughtry, Brittany L.

    AU - Chavez, Shawn

    PY - 2016/1/1

    Y1 - 2016/1/1

    N2 - Formation of a totipotent blastocyst capable of implantation is one of the first major milestones in early mammalian embryogenesis, but less than half of in vitro fertilized embryos from most mammals will progress to this stage of development. Whole chromosomal abnormalities, or aneuploidy, are key determinants of whether human embryos will arrest or reach the blastocyst stage. Depending on the type of chromosomal abnormality, however, certain embryos still form blastocysts and may be morphologically indistinguishable from chromosomally normal embryos. Despite the implementation of pre-implantation genetic screening and other advanced in vitro fertilization (IVF) techniques, the identification of aneuploid embryos remains complicated by high rates of mosaicism, atypical cell division, cellular fragmentation, sub-chromosomal instability, and micro-/multi-nucleation. Moreover, several of these processes occur in vivo following natural human conception, suggesting that they are not simply a consequence of culture conditions. Recent technological achievements in genetic, epigenetic, chromosomal, and non-invasive imaging have provided additional embryo assessment approaches, particularly at the single-cell level, and clinical trials investigating their efficacy are continuing to emerge. In this review, we summarize the potential mechanisms by which aneuploidy may arise, the various detection methods, and the technical advances (such as time-lapse imaging, “-omic” profiling, and next-generation sequencing) that have assisted in obtaining this data. We also discuss the possibility of aneuploidy resolution in embryos via various corrective mechanisms, including multi-polar divisions, fragment resorption, endoreduplication, and blastomere exclusion, and conclude by examining the potential implications of these findings for IVF success and human fecundity.

    AB - Formation of a totipotent blastocyst capable of implantation is one of the first major milestones in early mammalian embryogenesis, but less than half of in vitro fertilized embryos from most mammals will progress to this stage of development. Whole chromosomal abnormalities, or aneuploidy, are key determinants of whether human embryos will arrest or reach the blastocyst stage. Depending on the type of chromosomal abnormality, however, certain embryos still form blastocysts and may be morphologically indistinguishable from chromosomally normal embryos. Despite the implementation of pre-implantation genetic screening and other advanced in vitro fertilization (IVF) techniques, the identification of aneuploid embryos remains complicated by high rates of mosaicism, atypical cell division, cellular fragmentation, sub-chromosomal instability, and micro-/multi-nucleation. Moreover, several of these processes occur in vivo following natural human conception, suggesting that they are not simply a consequence of culture conditions. Recent technological achievements in genetic, epigenetic, chromosomal, and non-invasive imaging have provided additional embryo assessment approaches, particularly at the single-cell level, and clinical trials investigating their efficacy are continuing to emerge. In this review, we summarize the potential mechanisms by which aneuploidy may arise, the various detection methods, and the technical advances (such as time-lapse imaging, “-omic” profiling, and next-generation sequencing) that have assisted in obtaining this data. We also discuss the possibility of aneuploidy resolution in embryos via various corrective mechanisms, including multi-polar divisions, fragment resorption, endoreduplication, and blastomere exclusion, and conclude by examining the potential implications of these findings for IVF success and human fecundity.

    KW - Aneuploidy

    KW - Chromothripsis

    KW - Fragmentation

    KW - Micronuclei

    KW - Pre-implantation embryo

    UR - http://www.scopus.com/inward/record.url?scp=84952979110&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84952979110&partnerID=8YFLogxK

    U2 - 10.1007/s00441-015-2305-6

    DO - 10.1007/s00441-015-2305-6

    M3 - Article

    C2 - 26590822

    AN - SCOPUS:84952979110

    VL - 363

    SP - 201

    EP - 225

    JO - Cell and Tissue Research

    JF - Cell and Tissue Research

    SN - 0302-766X

    IS - 1

    ER -